Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-039260

Chairman and CEO bought 1,500 shares at an average $1.59 ($2,385)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2021-06-07 Purchase +500 $1.55 $775 10,756,915 D
Niihara Yutaka Chairman and CEO 2021-06-08 Purchase +1,000 $1.61 $1,610 10,757,915 D
Open-market purchases · 1,500 sh · avg $1.59 · $2,385
Loading xslF345X03/doc4.xml…